News - Appointments

Basilea Pharmaceutica Ltd has appointed Savitha Ram Moorthi as head of global quality management, effective 1 June, to oversee product quality at the Switzerland-based biopharmaceutical company.

Switzerland-based GeNeuro SA has hired the neurologist David Leppert to be chief medical officer and manage development of its programmes for neurodegenerative and autoimmune diseases.

Roland Wandeler, a former executive at Amgen Inc, has been appointed chief commercial officer at MorphoSys AG whose lead cancer product is under priority review at the US Food and Drug Administration.

Angus Lauder, a former executive at the UK’s leading cancer charity, has been named director of business development at Storm Therapeutics Ltd to help manage that company’s portfolio of epigenetic medicines.

Jonathan Tobin has been promoted to the position of managing director of Arix Bioscience Plc from investment director.

Edwin Moses, the former chief executive of Ablynx NV, has been appointed chairman of the board of directors of LabGenius Ltd, a protein engineering company that uses artificial intelligence, robotic automation and synthetic biology to d

UK-based e-Therapeutics Plc has appointed Laura Roca-Alonso as chief business officer following an executive restructuring at the company that earlier saw Ali Mortazavi, the former chief executive of Silence Therapeutics Plc, become exe

Sergio Quezada, an inventor and professor of cancer immunology, has become chief scientific officer of Achilles Therapeutics Ltd, a company that+ he helped found in 2016.

Arndt Schottelius, a veteran biotech executive, has been appointed chief scientific officer at Affimed NV to lead development of the company’s portfolio of innate cell engager-based medicines for cancer, and to manage its partnerships.

Genmab A/S has recruited Anthony Mancini to the newly created position of chief operating officer to oversee its commercial, corporate and business development as the company progresses more antibody therapies for cancer towards the mar